Herbal formula Yangyinjiedu induces lung cancer cell apoptosis via activation of early growth response 1

J Cell Mol Med. 2019 Sep;23(9):6193-6202. doi: 10.1111/jcmm.14501. Epub 2019 Jun 25.

Abstract

Traditional Chinese Medicine (TCM) has been extensively used in clinical practices and proven to be effective against cancer. However, the underlying mechanisms remain to be investigated. In this study, we examined the anticancer activities of Chinese herbal formula Yangyinjiedu (YYJD) and found that YYJD exhibits cytotoxicity against lung cancer cells. Transcriptome analysis indicated that 2178 genes were differentially expressed (P < 0.05) upon YYJD treatment, with 1464 being (67.2%) up-regulated. Among these, we found that the tumour suppressor early growth response 1 (EGR1) is the most activated. We demonstrated that EGR1 contributes to YYJD-induced apoptosis in A549. Through dissecting EGR1-associated transcriptional network, we identified 275 genes as EGR1 direct targets, some targets are involved in apoptosis. Lastly, we observed that YYJD enhances EGR1 expression and induces cell death in tumour xenografts. Collectively, these findings suggest that YYJD exerts its anticancer activities through EGR1 activation, thus providing the evidence for its potential clinical application for lung cancer patients.

Keywords: ChIP-seq; EGR1; lung cancer; traditional Chinese medicine; transcriptome.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • A549 Cells
  • Animals
  • Apoptosis / drug effects
  • Cell Proliferation / drug effects*
  • Drugs, Chinese Herbal / pharmacology*
  • Early Growth Response Protein 1 / genetics*
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / genetics
  • Lung Neoplasms / pathology
  • Medicine, Chinese Traditional
  • Mice
  • Neoplasm Proteins / genetics
  • Transcriptome / drug effects
  • Transcriptome / genetics*
  • Xenograft Model Antitumor Assays

Substances

  • Drugs, Chinese Herbal
  • EGR1 protein, human
  • Early Growth Response Protein 1
  • Neoplasm Proteins